Jinghua Pharmaceutical Group Co., Ltd.'s (SZSE:002349) Share Price Is Matching Sentiment Around Its Earnings

Simply Wall StNov 20 01:27 ET

Essence Pharmaceuticals: Report for the third quarter of 2024

SZSIOct 29 12:00 ET · Announcements

jinghua pharmaceutical group (002349.SZ) released its performance for the first three quarters, with a net income of 0.164 billion yuan, a year-on-year decrease of 15.93%.

jinghua pharmaceutical group (002349.SZ) released the quarterly report for the third quarter of 2024. In the first three quarters, the company achieved revenue...

Zhitong FinanceOct 29 09:37 ET

We Think Jinghua Pharmaceutical Group (SZSE:002349) Can Manage Its Debt With Ease

Simply Wall StOct 24 20:03 ET

Jinghua Pharmaceutical Plans to Divest Entire 18.6% Stake in Jinsili Pharmaceutical

MT NewswiresOct 10 23:43 ET

jinghua pharmaceutical group (002349.SZ): plans to sell the remaining equity of its joint venture subsidiary Jin Si Li Pharmaceutical Industry for 48 million yuan.

GeLonghui October 10th | Jinghua Pharmaceutical Group (002349.SZ) announced that the company plans to sell 18.6% of the shares of Jiangsu Jinsili Pharmaceutical Co., Ltd. (referred to as "Jinsili Pharmaceutical" or "trading symbol") through the National SME share transfer system, with a transaction amount of approximately 48 million yuan. After the transaction is completed, Jinghua Pharmaceutical Group will no longer hold equity in Jinsili Pharmaceutical.

Gelonghui FinanceOct 10 04:20 ET